Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gelb, D. J.
Right arrow Articles by Aminoff, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelb, D. J.
Right arrow Articles by Aminoff, M. J.
NEUROLOGY 1989;39:80
© 1989 American Academy of Neurology

Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

Douglas J. Gelb, MD, PhD, Daniel H. Lowenstein, MD and Michael J. Aminoff, MD, FRCP

Department of Neurology, University of California, San Francisco, CA.

We administered local injections of botulinum toxin to 20 patients with torticollis in a blinded, placebo-controlled study. Each patient received four sets of injections: three different doses of botulinum toxin and one placebo. The order of the sessions was random and unknown to the patients. Sixteen of the patients (80%) reported subjective improvement to at least one dose of botulinum toxin; 11 (55%) reported substantial improvement. No objective benefit was documented. Side effects were minor and transient, although dysphagia occurred in four. Some patients reported that the effect waned despite persistent relaxation or even flaccidity of previously overactive muscles, suggesting a change in the pattern of muscle activity after botulinum toxin injections.

Address correspondence and reprint requests to Dr. Aminoff, Box 0114, M-794, Department of Neurology, University of California, San Francisco, CA 94143.

Received May 16, 1988. Accepted for publication in final form July 12, 1988.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Ranoux, C Gury, J Fondarai, J L Mas, and M Zuber
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia
J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 459 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E. C DAVIS and M. P BARNES
Botulinum toxin and spasticity
J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 143 - 147.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
W Poewe, G Deuschl, A Nebe, E Feifel, J Wissel, R Benecke, K R Kessler, A O Ceballos-Baumann, A Ohly, W Oertel, et al.
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using DysportŪ
J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 13 - 17.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.